Tuesday May 29 | BioSpace
ChemoCentryx, Inc. Presents Data on CCX168, an Orally Administered...
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia ChemoCentryx, Inc.
Tuesday May 29 | BioSpace
ChemoCentryx, Inc. Announces Transfer of Existing Shares Between Current Stockholders
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia MOUNTAIN VIEW, Calif., May 25, 2012 -- ChemoCentryx, Inc.
ChemoCentryx Presents Data on CCX168, an Orally Administered Small...
ANCA-associated renal vaculitis can lead to renal failure and a high mortality if untreated.
ChemoCentryx Announces Transfer of Existing Shares Between Current Stockholders
ChemoCentryx, Inc. announced today a privately negotiated transfer of 749,999 shares of the Company's common stock between two current stockholders.
ChemoCentryx, Inc. Announces First Quarter 2012 Financial Results
HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia MOUNTAIN VIEW, Calif., May 10, 2012 -- ChemoCentryx, Inc.